
    
      The study protocol was approved by the Vinmec International Hospital Ethics Committee, and
      National Ethics Committees. The stem cell products are conducted in accordance with (GMP)
      requirements and Good Clinical Practice (GCP). All patients and primary caregivers will
      receive a written consent form, a cover letter and a clear explanation of the safety issues,
      potential risks and benefits, and the procedure involved. Moreover, patients will be provided
      the updated results related to disease and the study during conducting the study and will be
      fully funded by the project.
    
  